miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis
Li MaWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02142, USAJennifer J. YoungWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, Massachusetts, USAHarsha PrabhalaMedical Scientist Training Program, University of Virginia, Charlottesville, 22908, Virginia, USAElizabeth PanWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, Massachusetts, USAPieter MestdaghCenter for Medical Genetics, Ghent University Hospital, Ghent, 9000, BelgiumDaniel MuthDepartment of Tumor Genetics, German Cancer Center, Im Neuenheimer Feld 280, Heidelberg, 69120, GermanyJulie Teruya‐FeldsteinDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, 10021, New York, USAFerenc ReinhardtWhitehead Institute for Biomedical Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, 02142, Massachusetts, USATamer T. ÖnderMassachusetts Institute of Technology Ludwig Center for Molecular Oncology, Cambridge, 02142, Massachusetts, USAScott ValastyanMassachusetts Institute of Technology Ludwig Center for Molecular Oncology, Cambridge, 02142, Massachusetts, USAFrank WestermannDepartment of Tumor Genetics, German Cancer Center, Im Neuenheimer Feld 280, Heidelberg, 69120, GermanyFrank SpelemanCenter for Medical Genetics, Ghent University Hospital, Ghent, 9000, BelgiumJo VandesompeleCenter for Medical Genetics, Ghent University Hospital, Ghent, 9000, BelgiumRobert A. WeinbergMassachusetts Institute of Technology Ludwig Center for Molecular Oncology, Cambridge, 02142, Massachusetts, USA
2010en
ABI
Abstract
No abstract available.
Identifiers
Citations and references
Cited by 20 references